Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 6, 2025, through August 12, 2025
Business Overview: CCEP is a leading consumer goods company serving nearly 600 million consumers across 31 countries. It is listed on Euronext Amsterdam, NASDAQ, the London Stock Exchange, and Spanish Stock Exchanges.
Key Financial Metrics and Transactions
This filing details specific share repurchase transactions under an ongoing buyback programme. It does not contain revenue, profit, cash flow, or debt metrics for the period.
| Date of Purchase | Venue | Shares Purchased | Avg. Price (USD/GBP) |
|---|---|---|---|
| August 5, 2025 | US Trading Venues | 39,685 | USD 98.2737 |
| August 6, 2025 | US Trading Venues | 43,934 | USD 90.2826 |
| August 7, 2025 | US Trading Venues | 43,205 | USD 92.5718 |
| August 8, 2025 | US Trading Venues | 28,892 | USD 94.3925 |
| August 8, 2025 | London Trading Venues | 20,791 | GBP 69.7526 (LSE) |
| August 11, 2025 | US Trading Venues | 28,787 | USD 94.7287 |
| August 11, 2025 | London Trading Venues | 19,480 | GBP 70.6066 (LSE) |
Total Shares Repurchased in Period: 224,774 ordinary shares.
Material Changes and Programme Updates
Share Buyback Programme Status:
- First Tranche: Announced February 14, 2025 (up to EUR 275 million). Completed on May 23, 2025.
- Second Tranche: Announced May 23, 2025 (up to EUR 205 million). Completed on August 7, 2025.
- Third Tranche: Commenced August 8, 2025. Expected to run through November 6, 2025.
Third Tranche Details:
- Maximum Aggregate Amount: EUR 255,000,000.
- London Allocation: Up to EUR 80,000,000 (expected completion by October 30, 2025).
- US Allocation: Remainder of the tranche.
- Maximum Share Count: Up to 46,016,093 shares (subject to prior repurchases).
Overall Programme Goal: The Company expects to repurchase up to EUR 1 billion of ordinary shares in aggregate under the programme announced on February 14, 2025.
Guidance, Outlook, and Risks
Management Commentary: The primary purpose of the programme is to reduce the issued share capital of the Company. Purchases are executed via arrangements with Goldman Sachs & Co. LLC and Goldman Sachs International.
Risks and Contingencies:
- The filing includes a cautionary note regarding forward-looking statements, noting that actual results may differ materially due to risks outlined in the 2024 Annual Report on Form 20-F.
- Transactions are subject to applicable UK and US securities laws, including the Market Abuse Regulation and anti-manipulation provisions.
Financial Outlook: The filing text does not provide specific revenue, earnings, or cash flow guidance for the fiscal year.
Key Facts for Investor Verification
- Capital Return Execution: Verify the total capital returned to date against the EUR 1 billion aggregate target.
- Share Count Reduction: Confirm the impact of the 224,774 shares cancelled in this week on the total issued share capital.
- Tranche Progress: Monitor the execution of the third tranche (EUR 255 million) against the timeline ending November 6, 2025.
- Market Pricing: Note the volatility in repurchase prices, with US share prices ranging from approximately USD 88.80 to USD 98.72 during the week.
- Regulatory Compliance: Confirm adherence to the Market Abuse Regulation and UK Listing Rules for the London Trading Venues transactions.